Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS - Narrative (Details)

v3.24.1.1.u2
NATURE OF OPERATIONS - Narrative (Details)
3 Months Ended
Feb. 12, 2024
USD ($)
director
Mar. 31, 2024
subsidiary
Apr. 08, 2024
USD ($)
Number of indirect wholly-owned subsidiaries | subsidiary   2  
Danam Health, Inc. | Merger agreement between Danam Health Inc. and Assure Merger Corp.      
Number of directors in combined entity | director 5    
Directors and officers insurance maintenance period 6 years    
Maximum retained liability $ 500,000    
Termination fee payable 1,000,000    
Threshold reimbursement expenses payable by breaching party $ 250,000    
Danam Health, Inc. | Assure equityholders | Merger agreement between Danam Health Inc. and Assure Merger Corp.      
Percentage of capital stock in combined entity 10.00%    
Danam Health, Inc. | Danam equityholders | Merger agreement between Danam Health Inc. and Assure Merger Corp.      
Percentage of capital stock in combined entity 90.00%    
Subsequent Events | Merger agreement between Danam Health Inc. and Assure Merger Corp.      
Convertible promissory note     $ 1,000,000
Subsequent Events | Merger agreement between Danam Health Inc. and Assure Merger Corp. | Convertible Debt      
Interest rate     10.00%